Top tags

• Movers & shakers (253)
• Lehman Brothers (208)
• Citigroup (167)
• Merrill Lynch (163)
• Morgan Stanley (145)
• Goldman Sachs (141)
• private equity (124)
• Bank of America (117)
• M&A (116)
• bankruptcy (103)

Entries tagged "Dow Chemical"

Route 128 revisited

Despite a recession and the vagaries of science and technology, Boston's high-tech corridor continues to thrive. Not that there aren't concerns and anxieties.

A bigger tool kit

Lazard Middle Market's Michael McFadden and David Solomon (pictured).

Shearman helps Dow go salt-free

Dow Chemical used Shearman & Sterling's George Casey (pictured) and Daniel Litowitz on its Morton sale.

Return of the CVR

They haven't been seen for years, but in some pharma deals, these targeted options are beginning to re-emerge.

Dow, Rohm add to legal teams

Fried Frank's Daniel Bursky advised Paulson & Co. in its role in the Dow-Rohm deal.

Wachtell, Oslers oil Nova deal

Oslers' John Macfarlane was one of Nova's many advisers on its $2.3 billion sale to Ipic.

Risk Arbitrage: March 9, 2009

March 9, 12 and 20 are important days in the M&A world.

Risk Arbitrage: Feb. 9, 2009

2009 has begun better than it might have on the M&A front.

Fear of commitment

There is demand, there are deals, and there is even money, particularly among strategics. What's lacking in cross-border M&A is animal spirits. It'll take time.

Risk Arbitrage: Jan. 26, 2009

Even deals with committed, fully negotiated and syndicated debt for mergers without financing conditions trade at wide risk premiums.

Whipsawed

Dow Chemical finds it's a tough time to try to execute a multideal strategy.

Risk arb update: BCE

Can the banks drag the BCE deal past Dec. 11?

Spread too far

Amid turmoil, risk arbs have absorbed a lot of bad news, but some strategic deals look likely to close, and deal demand may be building.

Dow has the right chemistry

Citi takes credit for bringing Warren Buffett into the Dow-R&H fold.